ACADIA Pharmaceuticals Inc (ACAD) — Capital Reinvestment Ratio
ACADIA Pharmaceuticals Inc (ACAD) has a Capital Reinvestment Ratio of 0.08x as of June 2026, meaning it reinvests 0% of its operating cash flow ($134.76 Million) in capital expenditures ($10.30 Million). Check tangible net worth ratio of ACADIA Pharmaceuticals Inc to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ACADIA Pharmaceuticals Inc Capital Reinvestment Ratio (2023–2025)
This chart tracks ACADIA Pharmaceuticals Inc's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see ACAD operating cash flow.
Annual Capital Reinvestment Ratio for ACADIA Pharmaceuticals Inc (2023–2025)
Year-by-year Capital Reinvestment Ratio for ACADIA Pharmaceuticals Inc from 2023 to 2025. See ACAD free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | $109.84 Million | $4.69 Million | ▲ +1187.7% |
| 2024 | 0.00x | $157.72 Million | $523.00K | ▼ -99.9% |
| 2023 | 2.40x | $16.70 Million | $40.05 Million | — |